Akeso Biopharma, Inc. is a biopharmaceutical company based in Guangdong, China, focused on the research, development, and commercialization of innovative therapies. The company specializes in monoclonal antibodies and other biologics, targeting various diseases, including cancer and autoimmune disorders. With a commitment to advancing healthcare solutions, Akeso leverages cutting-edge technology and a robust research pipeline to address unmet medical needs, aiming to improve patient outcomes both domestically and globally.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#39 in Guangdong

#2,193 in China

#45,039 in the World

Guangdong, China

Akeso Biopharma, Inc.

Forward Citations = 3

8 inventors:

Baiyong Li (13 out of 22 patents)

Yu Xia (13 out of 22 patents)

Zhongmin Maxwell Wang (13 out of 22 patents)

4. Peng Zhang (11 out of 24 patents)

5. Xinghua Pang (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akeso Biopharma, Inc.. Retrieved from https://idiyas.com/company/akeso-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]